Analysis of Profitability Ratios
Quarterly Data
Profitability ratios measure the company ability to generate profitable sales from its resources (assets).
Profitability Ratios (Summary)
Intuitive Surgical Inc., profitability ratios (quarterly data)
Based on: 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).
| Profitability ratio | Description | The company |
|---|---|---|
| Gross profit margin | Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. | Intuitive Surgical Inc. gross profit margin ratio deteriorated from Q2 2023 to Q3 2023 and from Q3 2023 to Q4 2023. |
| Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | Intuitive Surgical Inc. operating profit margin ratio improved from Q2 2023 to Q3 2023 and from Q3 2023 to Q4 2023. |
| Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | Intuitive Surgical Inc. net profit margin ratio improved from Q2 2023 to Q3 2023 and from Q3 2023 to Q4 2023. |
| Profitability ratio | Description | The company |
|---|---|---|
| ROE | A profitability ratio calculated as net income divided by shareholders’ equity. | Intuitive Surgical Inc. ROE improved from Q2 2023 to Q3 2023 and from Q3 2023 to Q4 2023. |
| ROA | A profitability ratio calculated as net income divided by total assets. | Intuitive Surgical Inc. ROA improved from Q2 2023 to Q3 2023 and from Q3 2023 to Q4 2023. |
Gross Profit Margin
Intuitive Surgical Inc., gross profit margin calculation (quarterly data)
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | ||||||||||||||||||||||||||
| Gross profit | 1,277,400) | 1,167,200) | 1,171,900) | 1,113,000) | 1,110,900) | 1,052,100) | 1,023,300) | 1,009,700) | 1,060,800) | 971,400) | 1,023,700) | 902,600) | 895,800) | 724,300) | 502,900) | 738,200) | 896,000) | 785,600) | 759,000) | 669,600) | ||||||
| Revenue | 1,928,300) | 1,743,700) | 1,755,900) | 1,696,200) | 1,655,000) | 1,557,400) | 1,522,100) | 1,487,700) | 1,550,700) | 1,403,300) | 1,464,000) | 1,292,100) | 1,329,100) | 1,077,700) | 852,100) | 1,099,500) | 1,277,700) | 1,128,200) | 1,098,900) | 973,700) | ||||||
| Profitability Ratio | ||||||||||||||||||||||||||
| Gross profit margin1 | 66.39% | 66.61% | 66.74% | 66.86% | 67.44% | 67.77% | 68.16% | 68.84% | 69.32% | 69.12% | 68.69% | 66.48% | 65.65% | 66.44% | 67.07% | 69.04% | 69.45% | — | — | — | ||||||
| Benchmarks | ||||||||||||||||||||||||||
| Gross Profit Margin, Competitors2 | ||||||||||||||||||||||||||
| Abbott Laboratories | 50.28% | 49.97% | 50.23% | 50.66% | 51.54% | 52.60% | 53.54% | 52.44% | 52.21% | 52.01% | 50.69% | 51.25% | 50.49% | 50.18% | 50.97% | 52.13% | 52.46% | — | — | — | ||||||
| Cigna Group | 12.37% | 12.28% | 12.19% | 12.39% | 12.44% | 12.39% | 12.40% | 12.30% | 12.41% | 12.77% | 13.13% | 14.04% | 14.43% | 15.05% | 15.49% | 15.30% | 15.57% | — | — | — | ||||||
| CVS Health Corp. | 14.94% | 15.34% | 15.69% | 16.16% | 16.62% | 16.94% | 17.12% | 17.35% | 17.48% | 17.35% | 17.43% | 17.99% | 18.01% | 18.10% | 18.16% | 17.51% | 17.41% | — | — | — | ||||||
| Danaher Corp. | 58.74% | 58.68% | 59.08% | 60.14% | 60.21% | 60.65% | 60.77% | 60.77% | 60.95% | 60.44% | 59.24% | 57.60% | 55.98% | 55.04% | 55.28% | 55.85% | 55.74% | — | — | — | ||||||
| Elevance Health Inc. | 16.79% | 16.86% | 16.89% | 16.90% | 16.79% | 16.85% | 16.79% | 16.89% | 17.09% | 17.30% | 17.57% | 19.38% | 19.71% | 20.18% | 20.43% | 18.70% | 18.77% | — | — | — | ||||||
| Medtronic PLC | 65.67% | 66.43% | 67.21% | 67.61% | 67.98% | 67.89% | 67.39% | 66.53% | 65.19% | 63.85% | 64.57% | 65.76% | 67.41% | 68.96% | 69.22% | 69.62% | 70.04% | 70.33% | 70.40% | 70.25% | ||||||
| UnitedHealth Group Inc. | 23.64% | 24.16% | 24.08% | 24.20% | 24.09% | 23.74% | 23.51% | 23.31% | 23.60% | 23.75% | 23.80% | 25.79% | 25.62% | 25.83% | 25.95% | 23.52% | 23.19% | — | — | — | ||||||
Based on: 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).
1 Q4 2023 Calculation
Gross profit margin = 100
× (Gross profitQ4 2023
+ Gross profitQ3 2023
+ Gross profitQ2 2023
+ Gross profitQ1 2023)
÷ (RevenueQ4 2023
+ RevenueQ3 2023
+ RevenueQ2 2023
+ RevenueQ1 2023)
= 100 × (1,277,400 + 1,167,200 + 1,171,900 + 1,113,000)
÷ (1,928,300 + 1,743,700 + 1,755,900 + 1,696,200)
= 66.39%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| Gross profit margin | Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. | Intuitive Surgical Inc. gross profit margin ratio deteriorated from Q2 2023 to Q3 2023 and from Q3 2023 to Q4 2023. |
Operating Profit Margin
Intuitive Surgical Inc., operating profit margin calculation (quarterly data)
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | ||||||||||||||||||||||||||
| Income from operations | 450,200) | 465,800) | 463,200) | 387,600) | 372,500) | 398,900) | 397,600) | 408,100) | 450,400) | 442,600) | 511,200) | 416,800) | 415,800) | 270,400) | 80,600) | 283,000) | 397,600) | 365,700) | 359,000) | 252,200) | ||||||
| Revenue | 1,928,300) | 1,743,700) | 1,755,900) | 1,696,200) | 1,655,000) | 1,557,400) | 1,522,100) | 1,487,700) | 1,550,700) | 1,403,300) | 1,464,000) | 1,292,100) | 1,329,100) | 1,077,700) | 852,100) | 1,099,500) | 1,277,700) | 1,128,200) | 1,098,900) | 973,700) | ||||||
| Profitability Ratio | ||||||||||||||||||||||||||
| Operating profit margin1 | 24.80% | 24.66% | 24.34% | 24.21% | 25.35% | 27.05% | 28.48% | 30.69% | 31.89% | 32.55% | 31.27% | 26.01% | 24.09% | 23.95% | 25.86% | 30.52% | 30.69% | — | — | — | ||||||
| Benchmarks | ||||||||||||||||||||||||||
| Operating Profit Margin, Competitors2 | ||||||||||||||||||||||||||
| Abbott Laboratories | 16.15% | 15.02% | 15.23% | 16.77% | 19.16% | 20.95% | 22.42% | 20.73% | 19.56% | 20.04% | 18.46% | 17.97% | 15.48% | 13.39% | 12.78% | 14.18% | 14.21% | — | — | — | ||||||
| Cigna Group | 4.40% | 4.34% | 4.38% | 4.54% | 4.69% | 4.59% | 4.71% | 4.64% | 4.60% | 4.59% | 4.57% | 4.98% | 5.12% | 5.37% | 5.47% | 5.18% | 5.31% | — | — | — | ||||||
| CVS Health Corp. | 3.85% | 4.04% | 1.88% | 2.33% | 2.41% | 2.02% | 4.35% | 4.39% | 4.54% | 4.75% | 4.93% | 5.19% | 5.19% | 5.44% | 5.36% | 4.89% | 4.69% | — | — | — | ||||||
| Danaher Corp. | 21.77% | 23.53% | 24.82% | 26.85% | 27.61% | 27.35% | 25.44% | 25.23% | 25.35% | 24.63% | 25.04% | 22.30% | 18.99% | 17.61% | 17.37% | 18.01% | 18.25% | — | — | — | ||||||
| Elevance Health Inc. | 4.47% | 4.58% | 4.96% | 4.99% | 4.94% | 5.01% | 5.07% | 5.10% | 5.15% | 4.91% | 3.68% | 4.83% | 4.97% | 5.59% | 6.99% | 5.47% | 5.49% | — | — | — | ||||||
| Humana Inc. | 3.81% | 4.42% | 4.55% | 4.45% | 4.11% | 4.09% | 3.57% | 3.73% | 3.80% | 3.40% | 4.97% | 6.60% | 6.56% | 7.77% | 6.77% | 5.09% | 4.96% | — | — | — | ||||||
| Medtronic PLC | 17.56% | 18.17% | 19.02% | 19.37% | 18.15% | 17.89% | 16.68% | 14.78% | 14.89% | 11.44% | 12.77% | 14.25% | 16.57% | 20.67% | 20.47% | 21.25% | 20.51% | 20.48% | 20.22% | 21.70% | ||||||
| UnitedHealth Group Inc. | 8.80% | 8.86% | 8.83% | 8.87% | 8.83% | 8.65% | 8.32% | 8.19% | 8.40% | 7.91% | 7.73% | 9.24% | 8.76% | 9.55% | 9.89% | 8.12% | 8.19% | — | — | — | ||||||
Based on: 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).
1 Q4 2023 Calculation
Operating profit margin = 100
× (Income from operationsQ4 2023
+ Income from operationsQ3 2023
+ Income from operationsQ2 2023
+ Income from operationsQ1 2023)
÷ (RevenueQ4 2023
+ RevenueQ3 2023
+ RevenueQ2 2023
+ RevenueQ1 2023)
= 100 × (450,200 + 465,800 + 463,200 + 387,600)
÷ (1,928,300 + 1,743,700 + 1,755,900 + 1,696,200)
= 24.80%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | Intuitive Surgical Inc. operating profit margin ratio improved from Q2 2023 to Q3 2023 and from Q3 2023 to Q4 2023. |
Net Profit Margin
Intuitive Surgical Inc., net profit margin calculation (quarterly data)
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | ||||||||||||||||||||||||||
| Net income attributable to Intuitive Surgical, Inc. | 606,200) | 415,700) | 420,800) | 355,300) | 324,900) | 324,000) | 307,800) | 365,600) | 380,600) | 380,500) | 517,200) | 426,300) | 365,200) | 313,900) | 68,000) | 313,500) | 357,700) | 396,800) | 318,300) | 306,500) | ||||||
| Revenue | 1,928,300) | 1,743,700) | 1,755,900) | 1,696,200) | 1,655,000) | 1,557,400) | 1,522,100) | 1,487,700) | 1,550,700) | 1,403,300) | 1,464,000) | 1,292,100) | 1,329,100) | 1,077,700) | 852,100) | 1,099,500) | 1,277,700) | 1,128,200) | 1,098,900) | 973,700) | ||||||
| Profitability Ratio | ||||||||||||||||||||||||||
| Net profit margin1 | 25.24% | 22.14% | 21.38% | 20.40% | 21.25% | 22.52% | 24.05% | 27.84% | 29.85% | 30.78% | 31.43% | 25.78% | 24.33% | 24.45% | 26.07% | 30.11% | 30.80% | — | — | — | ||||||
| Benchmarks | ||||||||||||||||||||||||||
| Net Profit Margin, Competitors2 | ||||||||||||||||||||||||||
| Abbott Laboratories | 14.27% | 12.92% | 12.83% | 13.98% | 15.88% | 17.52% | 18.78% | 17.35% | 16.42% | 17.12% | 15.85% | 15.33% | 12.99% | 10.50% | 9.89% | 11.15% | 11.56% | — | — | — | ||||||
| Cigna Group | 2.66% | 2.81% | 3.59% | 3.71% | 3.72% | 3.69% | 3.08% | 3.07% | 3.11% | 4.97% | 4.93% | 5.22% | 5.31% | 3.40% | 3.43% | 3.22% | 3.35% | — | — | — | ||||||
| CVS Health Corp. | 2.34% | 2.48% | 0.86% | 1.20% | 1.29% | 1.00% | 2.66% | 2.68% | 2.72% | 2.67% | 2.60% | 2.74% | 2.68% | 3.00% | 3.14% | 2.77% | 2.59% | — | — | — | ||||||
| Danaher Corp. | 19.94% | 20.01% | 20.95% | 22.40% | 22.91% | 21.65% | 20.61% | 21.32% | 21.84% | 20.97% | 21.00% | 19.17% | 16.36% | 18.05% | 18.35% | 18.13% | 16.80% | — | — | — | ||||||
| Elevance Health Inc. | 3.52% | 3.63% | 3.89% | 3.89% | 3.87% | 4.09% | 4.13% | 4.37% | 4.46% | 4.17% | 3.32% | 3.82% | 3.78% | 4.26% | 5.27% | 4.42% | 4.66% | — | — | — | ||||||
| Humana Inc. | 2.36% | 2.97% | 3.45% | 3.28% | 3.03% | 3.07% | 3.52% | 3.52% | 3.54% | 3.31% | 3.13% | 4.78% | 4.43% | 5.67% | 5.00% | 3.89% | 4.20% | — | — | — | ||||||
| Medtronic PLC | 12.03% | 13.20% | 14.03% | 16.75% | 15.90% | 15.46% | 14.79% | 12.29% | 11.97% | 10.36% | 12.69% | 15.80% | 16.56% | 17.11% | 15.11% | 14.41% | 15.16% | 16.10% | 7.44% | 10.56% | ||||||
| UnitedHealth Group Inc. | 6.09% | 6.09% | 6.11% | 6.21% | 6.25% | 6.21% | 5.99% | 5.91% | 6.06% | 5.56% | 5.37% | 6.46% | 6.03% | 6.66% | 6.94% | 5.63% | 5.76% | — | — | — | ||||||
Based on: 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).
1 Q4 2023 Calculation
Net profit margin = 100
× (Net income attributable to Intuitive Surgical, Inc.Q4 2023
+ Net income attributable to Intuitive Surgical, Inc.Q3 2023
+ Net income attributable to Intuitive Surgical, Inc.Q2 2023
+ Net income attributable to Intuitive Surgical, Inc.Q1 2023)
÷ (RevenueQ4 2023
+ RevenueQ3 2023
+ RevenueQ2 2023
+ RevenueQ1 2023)
= 100 × (606,200 + 415,700 + 420,800 + 355,300)
÷ (1,928,300 + 1,743,700 + 1,755,900 + 1,696,200)
= 25.24%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | Intuitive Surgical Inc. net profit margin ratio improved from Q2 2023 to Q3 2023 and from Q3 2023 to Q4 2023. |
Return on Equity (ROE)
Intuitive Surgical Inc., ROE calculation (quarterly data)
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | ||||||||||||||||||||||||||
| Net income attributable to Intuitive Surgical, Inc. | 606,200) | 415,700) | 420,800) | 355,300) | 324,900) | 324,000) | 307,800) | 365,600) | 380,600) | 380,500) | 517,200) | 426,300) | 365,200) | 313,900) | 68,000) | 313,500) | 357,700) | 396,800) | 318,300) | 306,500) | ||||||
| Total Intuitive Surgical, Inc. stockholders’ equity | 13,307,600) | 12,539,000) | 11,879,100) | 11,217,700) | 11,041,900) | 11,515,400) | 12,023,000) | 12,102,300) | 11,901,100) | 11,410,900) | 10,837,500) | 10,153,500) | 9,731,500) | 9,257,800) | 8,740,500) | 8,506,700) | 8,263,800) | 7,761,400) | 7,265,300) | 7,024,200) | ||||||
| Profitability Ratio | ||||||||||||||||||||||||||
| ROE1 | 13.51% | 12.10% | 12.00% | 11.70% | 11.98% | 11.97% | 11.93% | 13.58% | 14.32% | 14.80% | 14.97% | 11.56% | 10.90% | 11.38% | 13.00% | 16.30% | 16.69% | — | — | — | ||||||
| Benchmarks | ||||||||||||||||||||||||||
| ROE, Competitors2 | ||||||||||||||||||||||||||
| Abbott Laboratories | 14.83% | 13.77% | 13.88% | 15.68% | 18.90% | 22.11% | 23.44% | 21.82% | 19.75% | 21.04% | 18.86% | 17.06% | 13.71% | 10.78% | 10.17% | 11.84% | 11.86% | — | — | — | ||||||
| Cigna Group | 11.17% | 11.61% | 14.64% | 15.17% | 14.86% | 14.69% | 11.94% | 11.69% | 11.39% | 17.68% | 16.73% | 17.52% | 16.81% | 11.03% | 11.11% | 10.91% | 11.26% | — | — | — | ||||||
| CVS Health Corp. | 10.91% | 11.57% | 4.02% | 5.57% | 5.84% | 4.46% | 10.86% | 10.83% | 10.54% | 10.20% | 9.83% | 10.44% | 10.35% | 11.56% | 12.14% | 11.08% | 10.39% | — | — | — | ||||||
| Danaher Corp. | 8.91% | 11.29% | 12.30% | 13.47% | 14.39% | 14.40% | 13.63% | 13.93% | 14.24% | 13.54% | 13.12% | 11.76% | 9.17% | 9.70% | 9.56% | 10.53% | 9.94% | — | — | — | ||||||
| Elevance Health Inc. | 15.23% | 15.82% | 16.78% | 16.62% | 16.59% | 17.26% | 17.04% | 17.36% | 16.93% | 15.44% | 12.10% | 13.92% | 13.77% | 14.61% | 17.17% | 15.08% | 15.15% | — | — | — | ||||||
| Humana Inc. | 15.31% | 17.79% | 20.07% | 18.79% | 18.33% | 17.27% | 20.29% | 19.81% | 18.24% | 16.44% | 16.72% | 26.23% | 24.53% | 26.34% | 24.29% | 21.16% | 22.49% | — | — | — | ||||||
| Medtronic PLC | 7.30% | 7.90% | 8.33% | 9.88% | 9.59% | 9.35% | 9.05% | 7.54% | 7.01% | 5.70% | 7.05% | 8.77% | 9.44% | 10.26% | 9.23% | 8.78% | 9.25% | 9.87% | 4.56% | 6.30% | ||||||
| UnitedHealth Group Inc. | 25.22% | 25.67% | 25.63% | 25.46% | 25.87% | 26.03% | 25.07% | 23.98% | 24.09% | 21.95% | 21.03% | 25.42% | 23.52% | 25.65% | 26.87% | 24.14% | 24.02% | — | — | — | ||||||
Based on: 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).
1 Q4 2023 Calculation
ROE = 100
× (Net income attributable to Intuitive Surgical, Inc.Q4 2023
+ Net income attributable to Intuitive Surgical, Inc.Q3 2023
+ Net income attributable to Intuitive Surgical, Inc.Q2 2023
+ Net income attributable to Intuitive Surgical, Inc.Q1 2023)
÷ Total Intuitive Surgical, Inc. stockholders’ equity
= 100 × (606,200 + 415,700 + 420,800 + 355,300)
÷ 13,307,600 = 13.51%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| ROE | A profitability ratio calculated as net income divided by shareholders’ equity. | Intuitive Surgical Inc. ROE improved from Q2 2023 to Q3 2023 and from Q3 2023 to Q4 2023. |
Return on Assets (ROA)
Intuitive Surgical Inc., ROA calculation (quarterly data)
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | ||||||||||||||||||||||||||
| Net income attributable to Intuitive Surgical, Inc. | 606,200) | 415,700) | 420,800) | 355,300) | 324,900) | 324,000) | 307,800) | 365,600) | 380,600) | 380,500) | 517,200) | 426,300) | 365,200) | 313,900) | 68,000) | 313,500) | 357,700) | 396,800) | 318,300) | 306,500) | ||||||
| Total assets | 15,441,500) | 14,712,700) | 13,903,300) | 13,053,200) | 12,974,000) | 13,260,800) | 13,705,200) | 13,678,400) | 13,555,000) | 12,934,600) | 12,297,000) | 11,540,400) | 11,168,900) | 10,617,500) | 10,103,600) | 9,891,100) | 9,733,200) | 9,131,300) | 8,531,600) | 8,234,900) | ||||||
| Profitability Ratio | ||||||||||||||||||||||||||
| ROA1 | 11.64% | 10.31% | 10.25% | 10.05% | 10.19% | 10.39% | 10.47% | 12.02% | 12.58% | 13.06% | 13.20% | 10.17% | 9.50% | 9.92% | 11.24% | 14.02% | 14.17% | — | — | — | ||||||
| Benchmarks | ||||||||||||||||||||||||||
| ROA, Competitors2 | ||||||||||||||||||||||||||
| Abbott Laboratories | 7.82% | 7.16% | 7.04% | 7.87% | 9.31% | 10.84% | 11.53% | 10.44% | 9.40% | 9.82% | 8.70% | 7.86% | 6.20% | 4.90% | 4.52% | 5.36% | 5.43% | — | — | — | ||||||
| Cigna Group | 3.38% | 3.54% | 4.43% | 4.56% | 4.63% | 4.59% | 3.59% | 3.53% | 3.46% | 5.44% | 5.29% | 5.55% | 5.44% | 3.31% | 3.30% | 3.18% | 3.28% | — | — | — | ||||||
| CVS Health Corp. | 3.34% | 3.42% | 1.17% | 1.66% | 1.82% | 1.36% | 3.55% | 3.43% | 3.39% | 3.23% | 3.12% | 3.22% | 3.11% | 3.41% | 3.51% | 3.13% | 2.98% | — | — | — | ||||||
| Danaher Corp. | 5.64% | 6.74% | 7.49% | 8.15% | 8.55% | 8.35% | 7.76% | 7.74% | 7.73% | 7.13% | 7.19% | 6.30% | 4.79% | 5.05% | 4.86% | 4.74% | 4.85% | — | — | — | ||||||
| Elevance Health Inc. | 5.50% | 5.50% | 5.87% | 5.69% | 5.86% | 6.03% | 6.05% | 6.21% | 6.26% | 5.63% | 4.40% | 4.93% | 5.28% | 5.72% | 6.72% | 5.80% | 6.21% | — | — | — | ||||||
| Humana Inc. | 5.29% | 5.39% | 5.98% | 5.69% | 6.52% | 5.53% | 6.71% | 6.55% | 6.61% | 5.90% | 6.52% | 9.95% | 9.63% | 10.79% | 9.11% | 7.55% | 9.31% | — | — | — | ||||||
| Medtronic PLC | 4.13% | 4.32% | 4.63% | 5.79% | 5.54% | 5.35% | 5.13% | 4.23% | 3.87% | 2.97% | 3.69% | 4.70% | 5.28% | 5.73% | 5.13% | 4.84% | 5.16% | 5.54% | 2.56% | 3.53% | ||||||
| UnitedHealth Group Inc. | 8.18% | 7.69% | 7.53% | 7.30% | 8.19% | 7.99% | 7.93% | 7.89% | 8.15% | 7.24% | 6.90% | 8.23% | 7.81% | 8.76% | 8.88% | 7.27% | 7.96% | — | — | — | ||||||
Based on: 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).
1 Q4 2023 Calculation
ROA = 100
× (Net income attributable to Intuitive Surgical, Inc.Q4 2023
+ Net income attributable to Intuitive Surgical, Inc.Q3 2023
+ Net income attributable to Intuitive Surgical, Inc.Q2 2023
+ Net income attributable to Intuitive Surgical, Inc.Q1 2023)
÷ Total assets
= 100 × (606,200 + 415,700 + 420,800 + 355,300)
÷ 15,441,500 = 11.64%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| ROA | A profitability ratio calculated as net income divided by total assets. | Intuitive Surgical Inc. ROA improved from Q2 2023 to Q3 2023 and from Q3 2023 to Q4 2023. |